Joshua Sharfstein, the Obama administration’s nominee for the No. 2 job at the FDA, will become acting chief of the agency on Monday, according to media reports. Here’s a news alert from InsideHealthPolicy.com “Joshua Sharfstein, selected by the White House for the No. 2 job at FDA, will take over Monday as acting commissioner. […]
The benefits of early anti-HIV therapy for patients with an opportunistic infection outweigh the risks, according to new guidelines from the CDC. The guidelines, developed with the NIH and the Infectious Diseases Society of America, say that for most such infections, early antiretroviral therapy will lead to better outcomes. One exception, however, is tuberculosis. […]
Some of the greatest minds on TB gathered this week here in Rio de Janeiro, Brazil, where advocates, researchers, and donors from all over the world attended the Stop TB Partnership. TB is killing nearly 2 million people a year, yet still gets far too little attention, and the purpose of the conference was to […]
HIV
As the federal Ending the HIV epidemic takes form, experts talk details, challenges: “How do we get there from here?” WASHINGTON, DC – Nearly four decades […]
Tuberculosis
Patients treated for multidrug-resistant tuberculosis with an experimental regimen containing a repurposed drug for a year had similar rates of successful outcomes as patients treated with […]
Research & Development
While a World Health Organization-led strategy aims to provide 1.4 billion doses of vaccine against yellow fever to achieve 80% vaccination coverage across countries by 2026 […]
Policy
The following is a guest post By Sharon Weir, Ph.D. of MEASURE Evaluation The Priorities for Local AIDS Control Efforts — PLACE –method aims to improve […]